Bertin Pharma Bertin Pharma
Select your search
Contact us
You are here : All Press Releases

All Press Releases

Back to Press & Media

December 2015: Bertin Pharma & LXRepair sign up for a kit to quantify DNA repair

Bertin Pharma and LXRepair sign up an agreement for manufacturing and distributing a kit to quantify DNA repair enzyme activities : Glyco-SPOT DNA Repair Assay kit

see Glyco-Spot Press release

July 2015: Bertin Pharma is named once again amongst the CRO Leadership Awards

Bertin Pharma reiterates its top position in the categories "regulatory affairs" and "productivity" in the survey conducted by the company Nice Insight.

see CRO Leadership Awards Press Release

December 2014: Launching of new kits to assay acylated & non-acylated Ghrelin

Bertin Pharma is completing its existing range of assay products dedicated to Obesity-Diabetes pathologies: 7 human and rat/mouse EIA kits available to assay the specific hormone secreted primarily by cells of the stomach: Ghrelin.

see Ghrelin Launching Press Release

January 2014: Bertin Pharma acquires Johnson & Johnson Sante Beaute France R&D

On January 31st, 2014, Bertin Pharma, a Bertin Technologies subsidiary specialising in pharmaceutical R&D contract services and a bioreagent supplier, has acquired a 1500 sqm. R&D facility located in Martillac (south-west of France) dedicated to the formulation and the production of clinical batches of over-the-counter (OTC) drugs from Johnson & Johnson Santé Beauté France (JJSBF).

In addition to the acquisition of the R&D facility, the transaction includes the entry into a services agreement through which Bertin Pharma will provide R&D services to JJSBF.

see Bertin Pharma – Johnson & Johnson press release

March 2014: Harlan Contract Research Services (CRS) & Bertin Pharma Sign Strategic Collaboration Agreement

Harlan Contract Research Services and Bertin Pharma, headquartered in Montigny-le-Bretonneux, France, announced a strategic partnership to offer a comprehensive package for early drug development. Under the agreement, the companies will offer a wider range of drug discovery and translational medicine services, including expanded profiling and molecule testing, especially in the context of regulatory

see Harlan & Bertin Pharma Press Release

June 2012: Unique in Europe, the cytometer mass CyTOF ™ was inaugurated on the site of CEA Fontenay-aux-Roses

It will be used for research on infectious diseases, vaccines and antivirals. Proposed at the initiative of three partners: CEA, Université Paris Sud and Bertin Pharma, the project won the tender EquipEx 2010 (Future Investments, Equipment of Excellence) and adds activities cytometry platform FlowCyTech service immunovirology CEA. The joint offering services Bertin Pharma and CEA was presented on this occasion, as the PharmImmune.

see mass CyTOF Press release


Bertin Pharma - Institutionnel

Follow Us

Linkedin Youtube Twitter Google+

Contact us

Any project? Any challenge? We are in!
+33 (0) 139 306 036
Any questions? Contact us

Parc d’Activités du Pas du Lac
10 bis avenue Ampère
78180 Montigny le Bretonneux - France
Find us


Do you want to be kept updated with Bertin Pharma's latest news?

Manage my subscriptions